Octavia tech to predict viruses

New tech is being developed which could help the world become more proactive to the outbreak of viruses.

Octavia is an AI, created by Apriori Bio, which combines experimental biology with algorithms to create synthetic variants of a given virus and tests how likely they are to escape vaccines. The biotech can then reverse the process to design vaccines and antibodies based on the AI data.

Octavia will test how the synthetic virus variants it creates bind to antibodies to design more effective virus protection.

Apriori Bio was founded during the COVID pandemic and aims to tackle multiple ‘ultra dynamic’ viruses outside of SARS-CoV-2 including flu and HIV in an effort to be better prepared for annual virus outbreaks. It features a number of ex-US government leaders on its advisory board including a former commissioner and vaccine official from the FDA, a former vaccine strategist from Moderna and a former assistant secretary of defense from the Obama administration.

Back to the list